Primary hyperparathyroidism also markedly increases the risk of death. Which is cool because when I'm dead, I won't suffer from these symptoms.
Thankfully, the operation, now scheduled for 26 November, should help.
Thankfully, the operation, now scheduled for 26 November, should help.
November 1, 2026 at 8:12 AM
Primary hyperparathyroidism also markedly increases the risk of death. Which is cool because when I'm dead, I won't suffer from these symptoms.
Thankfully, the operation, now scheduled for 26 November, should help.
Thankfully, the operation, now scheduled for 26 November, should help.
New ASN Kidney Translation Podcast episode reviews 2 late-breaking clinical trials published simultaneously with #KidneyWk: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. kidney.pub/KTPOD102426
October 30, 2026 at 6:00 PM
New ASN Kidney Translation Podcast episode reviews 2 late-breaking clinical trials published simultaneously with #KidneyWk: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. kidney.pub/KTPOD102426
anyone have hyperparathyroidism? My blood test just confirmed it.. waiting to see my endocrinologist, and more blood tests... I need a hip replacement also.. that is on hold until I get this sorted out...
October 31, 2026 at 11:06 PM
anyone have hyperparathyroidism? My blood test just confirmed it.. waiting to see my endocrinologist, and more blood tests... I need a hip replacement also.. that is on hold until I get this sorted out...
"I’m a GP – seven health symptoms people dismiss too easily"
apple.news/AO-zHR0caRg-...
At least 2, maybe more, of these symptoms can be caused by my condition, primary hyperparathyroidism
Yet the medical profession often gaslights people who suffer from it.
apple.news/AO-zHR0caRg-...
At least 2, maybe more, of these symptoms can be caused by my condition, primary hyperparathyroidism
Yet the medical profession often gaslights people who suffer from it.
I’m a GP – seven health symptoms people dismiss too easily — The i Paper
From waking up too early to brain fog, here are the everyday things we should pay more attention to
apple.news
October 31, 2026 at 7:35 PM
"I’m a GP – seven health symptoms people dismiss too easily"
apple.news/AO-zHR0caRg-...
At least 2, maybe more, of these symptoms can be caused by my condition, primary hyperparathyroidism
Yet the medical profession often gaslights people who suffer from it.
apple.news/AO-zHR0caRg-...
At least 2, maybe more, of these symptoms can be caused by my condition, primary hyperparathyroidism
Yet the medical profession often gaslights people who suffer from it.
A Study of Multimodality Imaging Features of Brown Tumor or Osteitis Fibrosa Cystica
Brown tumor, also known as osteitis fibrosa cystica, is a rare but significant manifestation of hyperparathyroidism…
📄 PDF: sjoranm.com/sjoranm/article/download/36/37
#SJORANM #Radiology #NuclearMedicine
Brown tumor, also known as osteitis fibrosa cystica, is a rare but significant manifestation of hyperparathyroidism…
📄 PDF: sjoranm.com/sjoranm/article/download/36/37
#SJORANM #Radiology #NuclearMedicine
A Study of Multimodality Imaging Features of Brown Tumor or Osteitis Fibrosa Cystica
Swiss J. Radiol. Nucl. Med. · Vol. 10 No. 1 · 2024-07-30 · DOI doi.org/10.59667/sjoranm.v10i1.16 · Brown tumor, also known as osteitis fibrosa cystica, is a rare but significant manifestation of hyperparathyroidism characterized by focal bone lesions resulting from excessive osteoclastic…
sjoranm.com
October 28, 2026 at 6:15 PM
A Study of Multimodality Imaging Features of Brown Tumor or Osteitis Fibrosa Cystica
Brown tumor, also known as osteitis fibrosa cystica, is a rare but significant manifestation of hyperparathyroidism…
📄 PDF: sjoranm.com/sjoranm/article/download/36/37
#SJORANM #Radiology #NuclearMedicine
Brown tumor, also known as osteitis fibrosa cystica, is a rare but significant manifestation of hyperparathyroidism…
📄 PDF: sjoranm.com/sjoranm/article/download/36/37
#SJORANM #Radiology #NuclearMedicine
🎧 New: Hyperparathyroidism. Primary, secondary and tertiary: read the calcium and PTH pattern.
• Primary: raised calcium and PTH, usually a single adenoma
• Secondary (CKD): low or normal calcium, raised PTH
▶ https://youtu.be/PyQ73MjoK6c
#MedEd #USMLE
• Primary: raised calcium and PTH, usually a single adenoma
• Secondary (CKD): low or normal calcium, raised PTH
▶ https://youtu.be/PyQ73MjoK6c
#MedEd #USMLE
October 24, 2026 at 7:01 AM
🎧 New: Hyperparathyroidism. Primary, secondary and tertiary: read the calcium and PTH pattern.
• Primary: raised calcium and PTH, usually a single adenoma
• Secondary (CKD): low or normal calcium, raised PTH
▶ https://youtu.be/PyQ73MjoK6c
#MedEd #USMLE
• Primary: raised calcium and PTH, usually a single adenoma
• Secondary (CKD): low or normal calcium, raised PTH
▶ https://youtu.be/PyQ73MjoK6c
#MedEd #USMLE
Endo Research Conf: Dr Bilezikian, #calcium & #bone 🦴 expert from Columbia U, shared excellent review of hyperparathyroidism. Discussion of indications for surgery & # 1 predictor of good outcome, regardless of imaging localization, is an expert surgeon! We are lucky to have them here!
October 22, 2026 at 11:42 AM
They also suggested it was in my head or my heart.
(How about arse or elbow?)
Funnily enough, my illness, primary hyperparathyroidism, affects more women than men and is most commonly diagnosed when patients are in their 50s.
It also shares certain symptoms associated with the menopause.
(How about arse or elbow?)
Funnily enough, my illness, primary hyperparathyroidism, affects more women than men and is most commonly diagnosed when patients are in their 50s.
It also shares certain symptoms associated with the menopause.
October 19, 2026 at 8:28 AM
They also suggested it was in my head or my heart.
(How about arse or elbow?)
Funnily enough, my illness, primary hyperparathyroidism, affects more women than men and is most commonly diagnosed when patients are in their 50s.
It also shares certain symptoms associated with the menopause.
(How about arse or elbow?)
Funnily enough, my illness, primary hyperparathyroidism, affects more women than men and is most commonly diagnosed when patients are in their 50s.
It also shares certain symptoms associated with the menopause.
Maddening, especially when the high calcium caused by the hyperparathyroidism can cause mental health issues & when they should also know that the fatigue of chronic illness is nothing like not being 20 anymore. I hope the surgery is successful & everything returns to normal soon
October 19, 2026 at 2:10 PM
Maddening, especially when the high calcium caused by the hyperparathyroidism can cause mental health issues & when they should also know that the fatigue of chronic illness is nothing like not being 20 anymore. I hope the surgery is successful & everything returns to normal soon
Primary hyperparathyroidism affects 1 in 100 people, with early PTH testing preventing potentially life-threatening cardiac complications.
https://news.gmj.ge/briefs/1-in-100-primary-hyperparathyroidisms-underrecognized-cardiac-threat/
https://news.gmj.ge/briefs/1-in-100-primary-hyperparathyroidisms-underrecognized-cardiac-threat/
1 in 100: Primary Hyperparathyroidism’s Underrecognized Cardiac Threat
Primary hyperparathyroidism affects 1 in 100 people, with early PTH testing preventing potentially life-threatening cardiac complications.
news.gmj.ge
October 17, 2026 at 11:28 PM
Primary hyperparathyroidism affects 1 in 100 people, with early PTH testing preventing potentially life-threatening cardiac complications.
https://news.gmj.ge/briefs/1-in-100-primary-hyperparathyroidisms-underrecognized-cardiac-threat/
https://news.gmj.ge/briefs/1-in-100-primary-hyperparathyroidisms-underrecognized-cardiac-threat/
Co-occurrence of pathogenic CYP24A1 gene variants and primary hyperparathyroidism: a diagnostic challenge
Simone Della Valentina, Laura Pierotti, Chiara Sardella, Anna Dal Lago, Maria Adelaide Caligo, Agnese Giamborino, Filomena Cetani
Published: 09 October
academic.oup.com/jbmrplus/adv...
Simone Della Valentina, Laura Pierotti, Chiara Sardella, Anna Dal Lago, Maria Adelaide Caligo, Agnese Giamborino, Filomena Cetani
Published: 09 October
academic.oup.com/jbmrplus/adv...
October 15, 2026 at 7:25 PM
Co-occurrence of pathogenic CYP24A1 gene variants and primary hyperparathyroidism: a diagnostic challenge
Simone Della Valentina, Laura Pierotti, Chiara Sardella, Anna Dal Lago, Maria Adelaide Caligo, Agnese Giamborino, Filomena Cetani
Published: 09 October
academic.oup.com/jbmrplus/adv...
Simone Della Valentina, Laura Pierotti, Chiara Sardella, Anna Dal Lago, Maria Adelaide Caligo, Agnese Giamborino, Filomena Cetani
Published: 09 October
academic.oup.com/jbmrplus/adv...
I hope you get better soon. Not a pleasant experience.
As for me, I have a fairly common condition, primary hyperparathyroidism, that is often mismanaged by doctors and where a lot of gaslighting occurs.
A condition that ruins lives, can shorten them and is easily fixable via a simple operation.
As for me, I have a fairly common condition, primary hyperparathyroidism, that is often mismanaged by doctors and where a lot of gaslighting occurs.
A condition that ruins lives, can shorten them and is easily fixable via a simple operation.
October 9, 2026 at 5:04 PM
I hope you get better soon. Not a pleasant experience.
As for me, I have a fairly common condition, primary hyperparathyroidism, that is often mismanaged by doctors and where a lot of gaslighting occurs.
A condition that ruins lives, can shorten them and is easily fixable via a simple operation.
As for me, I have a fairly common condition, primary hyperparathyroidism, that is often mismanaged by doctors and where a lot of gaslighting occurs.
A condition that ruins lives, can shorten them and is easily fixable via a simple operation.
RRIDs were included in this in AACE Endocrinology and Diabetes paper. We value the author's support of reproducibility. #accelerateopenscience #ReproducibleResearch #RRID
ESTIMATED FRACTURE RISK USING THE FRAX SCORE IN ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM
Read the full paper: ESTIMATED FRACTURE RISK USING THE FRAX SCORE IN ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM
doi.org
October 9, 2026 at 7:06 AM
RRIDs were included in this in AACE Endocrinology and Diabetes paper. We value the author's support of reproducibility. #accelerateopenscience #ReproducibleResearch #RRID
Hypercalcemia Treatment Market Demand, Share & Growth by 2034
The global Hypercalcemia Treatment Marketis gaining momentum as the need for effective treatments increases for managing elevated calcium levels in the blood. Hypercalcemia is commonly associated with conditions such as cancer,…
The global Hypercalcemia Treatment Marketis gaining momentum as the need for effective treatments increases for managing elevated calcium levels in the blood. Hypercalcemia is commonly associated with conditions such as cancer,…
Hypercalcemia Treatment Market Demand, Share & Growth by 2034
The global Hypercalcemia Treatment Marketis gaining momentum as the need for effective treatments increases for managing elevated calcium levels in the blood. Hypercalcemia is commonly associated with conditions such as cancer, hyperparathyroidism, kidney disorders, and certain medication-related complications. Market Overview Hypercalcemia Treatment market size is expected to reach US$ 2.70 Billion by 2034 from US$ 1.27 Billion in 2025. The market is anticipated to register a CAGR of 8.74% during the forecast period 2026–2034.
www.news24.ph
October 9, 2026 at 10:28 AM
Hypercalcemia Treatment Market Demand, Share & Growth by 2034
The global Hypercalcemia Treatment Marketis gaining momentum as the need for effective treatments increases for managing elevated calcium levels in the blood. Hypercalcemia is commonly associated with conditions such as cancer,…
The global Hypercalcemia Treatment Marketis gaining momentum as the need for effective treatments increases for managing elevated calcium levels in the blood. Hypercalcemia is commonly associated with conditions such as cancer,…
So apparently eating crisps and drinking pop regularly increases the risk of CVE by 14%.
Meanwhile, my disease, Primary Hyperparathyroidism, increases the risk of death by 72% compared to people who don't have it.
And yet you have to FIGHT to get the operation which is the only way to cure it.
Meanwhile, my disease, Primary Hyperparathyroidism, increases the risk of death by 72% compared to people who don't have it.
And yet you have to FIGHT to get the operation which is the only way to cure it.
September 29, 2026 at 1:08 PM
So apparently eating crisps and drinking pop regularly increases the risk of CVE by 14%.
Meanwhile, my disease, Primary Hyperparathyroidism, increases the risk of death by 72% compared to people who don't have it.
And yet you have to FIGHT to get the operation which is the only way to cure it.
Meanwhile, my disease, Primary Hyperparathyroidism, increases the risk of death by 72% compared to people who don't have it.
And yet you have to FIGHT to get the operation which is the only way to cure it.
My husband had hyperparathyroidism years back and got very ill. It was around the same time that Gary Shandling died of it. As soon as they removed the two parathyroids that were enlarged he felt completely fine and could eat and think. It was a scary experience.
September 28, 2026 at 10:39 PM
My husband had hyperparathyroidism years back and got very ill. It was around the same time that Gary Shandling died of it. As soon as they removed the two parathyroids that were enlarged he felt completely fine and could eat and think. It was a scary experience.
Denosumab found to have higher rates of hypocalcemia and hypophosphatemia than zoledronate in patients with advanced CKD.
www.ajkd.org/article/S027...
www.ajkd.org/article/S027...
Risks of Hypocalcemia and Other Bone Mineral Disorders for Denosumab Versus Zoledronate Across the Spectrum of Kidney Function: A Target Trial Emulation
Denosumab, an osteoporosis medication, may induce hypocalcemia, secondary hyperparathyroidism
(SHPT), and hypophosphatemia. We studied these risks compared with zoledronate and
whether the risks diffe...
www.ajkd.org
September 28, 2026 at 10:41 PM
Denosumab found to have higher rates of hypocalcemia and hypophosphatemia than zoledronate in patients with advanced CKD.
www.ajkd.org/article/S027...
www.ajkd.org/article/S027...
Yeeeeehhh, time to celebrate! 🎉🥳
A PTH blood test should help determine whether this is related to hyperparathyroidism.
No tumor. Congratulations.
A PTH blood test should help determine whether this is related to hyperparathyroidism.
No tumor. Congratulations.
September 28, 2026 at 5:54 PM
Yeeeeehhh, time to celebrate! 🎉🥳
A PTH blood test should help determine whether this is related to hyperparathyroidism.
No tumor. Congratulations.
A PTH blood test should help determine whether this is related to hyperparathyroidism.
No tumor. Congratulations.
And when I come back, pre-op.
Primary hyperparathyroidism is lovely. Not.
Primary hyperparathyroidism is lovely. Not.
September 27, 2026 at 5:04 PM
And when I come back, pre-op.
Primary hyperparathyroidism is lovely. Not.
Primary hyperparathyroidism is lovely. Not.
Primary Hyperparathyroidism in Celiac Disease: Diagnostic Challenges and Therapeutic Strategies. QV Luong et al. Nutrients 2026 Sep 21 shorturl.at/SKQQN ... highlights a gap in our understanding of the pathogenesis linking these two conditions ...recommendations
September 27, 2026 at 9:23 AM
Primary Hyperparathyroidism in Celiac Disease: Diagnostic Challenges and Therapeutic Strategies. QV Luong et al. Nutrients 2026 Sep 21 shorturl.at/SKQQN ... highlights a gap in our understanding of the pathogenesis linking these two conditions ...recommendations
Parathyroid Carcinoma and Primary Hyperparathyroidism: Trends and Outcomes. S Baek et al. Endocr Relat Cancer 2026 Sep 23 shorturl.at/QyAxA ... rising burden of parathyroid disease in Korea and underscore the need for cardiometabolic risk surveillance
September 27, 2026 at 8:52 AM
Parathyroid Carcinoma and Primary Hyperparathyroidism: Trends and Outcomes. S Baek et al. Endocr Relat Cancer 2026 Sep 23 shorturl.at/QyAxA ... rising burden of parathyroid disease in Korea and underscore the need for cardiometabolic risk surveillance
Bone-modifying agents may alter biochemical presentation and operative findings in primary hyperparathyroidism. AC Chmiel et al. Surgery 2026 Sep 1 shorturl.at/Life8 ... associated with a distinct biochemical profile and a higher prevalence of multigland disease
September 27, 2026 at 7:54 AM
Bone-modifying agents may alter biochemical presentation and operative findings in primary hyperparathyroidism. AC Chmiel et al. Surgery 2026 Sep 1 shorturl.at/Life8 ... associated with a distinct biochemical profile and a higher prevalence of multigland disease